A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Slovakia- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Slovakia76 clinical trials in Trnava, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for non-small cell lung cancer, advanced breast cancer, and head and neck cancer. Studies are evaluating new combination therapies and investigating targeted treatments for patients with specific biomarkers.
Multiple ongoing trials investigating treatments for relapsing multiple sclerosis. Research includes comparative studies of new therapeutic agents and evaluation of treatment effectiveness in patients transitioning between therapies.
Research focusing on atherosclerotic cardiovascular disease and stroke prevention. Trials are evaluating new treatments for reducing major cardiovascular events and managing complications in high-risk patients.
Studies examining treatments for hidradenitis suppurativa, chronic plaque psoriasis, and vitiligo. Research includes both adult and pediatric populations, with a focus on novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.